Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives. The Company is currently advancing a diverse range of anti-infectives, including a vaccine candidate to eliminate a serious biological weapon threat, a topical antiparasitic for the treatment of a disfiguring disease, and a novel easy to use, liquid oral formulation targeting parasitic and anaerobic infections. 

Biotechnology

Health Care

Therapeutics

Appili Therapeutics

Don Cilla

Leona Saunders

Art Baran

Carl Gelhaus

Gary Nabors

Kenneth Howling

The executive team at Appili Therapeutics has a wealth of experience in both academia and the military. Assistant Professor at United States Military Academy at West Point, Deputy Director, Office of Regulated Activities (ORA) at US Army Medical Materiel Development Activity (USAMMDA), Adjunct Associate Professor at University of Maryland, Deputy Director, Division of Regulated Activities and Compliance (DRAC) at USAMMDA. This experience gives them a unique perspective on the development and regulation of medical products.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Appili Therapeutics

Board of Directors

Leadership Team